Filter posts

USPTO Issues New Myriad Guidance

On Tuesday, December 16 the United States Patent and Trademark Office issued a revised guidance …

Patently Biotech’s Top Articles of 2014

It’s been a whirlwind year for IP. From international trade negotiations, to revised PTO guidelines …

BIO Coalition Submits Patent Reform Letter to Congress

BIO, alongside a coalition of patent holders and inventors, submitted a letter to the chairmen …

Now What is Patentable?

On Tuesday of the Pacific Rim Summit, experts from Knobbe Martens, BIO, and Synthetic Genomics explored the …

Indian Patents Ensure Wide Access to Drugs, Without Raising Prices

Two recent studies on Indian drugs have shown that patent protection does not dramatically increase …

Patent Trolls and Nigerian Scammers

What do patent trolls and Nigerian princes have in common? Two things come to mind. …

New Report Emphasizes the Role of Patent Protection in the Global Diffusion of New Drugs

A new report from the National Bureau of Economic Research (NBER) has determined that strong …

Patents Not an Issue in the Fight Against Ebola

As of October 23,2014 more than 4,900 people have died from the current Ebola outbreak, …

Need for Patent Reform May be Overblown

Amid the cacophony of calls for patent reform legislation, mounting evidence demonstrates patent trolling may …

BIO Submits Joint Supplemental Comments on the USPTO March Guidance

Last week BIO, alongside a number of member companies and private individuals, submitted supplemental comments …